Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings

Shares (Q2 2026)
217,524
Value
$1.15M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ACRS by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026217,524$1.15M<0.1%−88,312−28.9%ReducedHolders
Q1 2026305,836$1.15M<0.1%−1120.0%ReducedHolders
Q4 2025305,948$920.9K<0.1%−3,369−1.1%ReducedHolders
Q3 2025309,317$587.7K<0.1%−12,500−3.9%ReducedHolders
Q2 2025321,817$457.0K<0.1%+5,753+1.8%AddedHolders
Q1 2025316,064$483.6K<0.1%+53,116+20.2%AddedHolders
Q4 2024262,948$652.1K<0.1%−42,866−14.0%ReducedHolders
Q3 2024305,814$352.0K<0.1%−6,900−2.2%ReducedHolders
Q2 2024312,714$344.0K<0.1%+1000.0%AddedHolders
Q1 2024312,614$386.0K<0.1%−30,410−8.9%ReducedHolders
Q4 2023343,024$361.0K<0.1%−26,778−7.2%ReducedHolders
Q3 2023369,802$2.53M<0.1%−10,000−2.6%ReducedHolders
Q2 2023379,802$3.94M<0.1%+187,479+97.5%AddedHolders
Q1 2023192,323$1.56M<0.1%−101−0.1%ReducedHolders
Q4 2022192,424$3.03M<0.1%+134,071+229.8%AddedHolders
Q3 202258,353$919.0K<0.1%−1,739−2.9%ReducedHolders
Q2 202260,092$840.0K<0.1%−3,207−5.1%ReducedHolders
Q1 202263,299$1.09M<0.1%−4,580−6.7%ReducedHolders
Q4 202167,879$987.0K<0.1%−399−0.6%ReducedHolders
Q3 202168,278$1.23M<0.1%+3,800+5.9%AddedHolders
Q2 202164,478$1.13M<0.1%00.0%UnchangedHolders
Q1 202164,478$1.62M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.